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independent predictors of MT. The area under the curve 
values for Fbg and BE were 0.765 and 0.845, respectively, 
and the optimal cutoff values of Fbg and BE were 211 mg/
dL and −1.4, respectively.
Conclusions Fbg and BE levels can be used as an inde-
pendent predictor for MT.
Keywords Massive transfusion · Fibrinogen level · 
Scoring system · Blunt trauma patients
Introduction
Trauma is a leading cause of death in persons under the age 
of 40 and severe hemorrhage is a major cause of mortal-
ity in both civilian and military trauma [1–3]. Death from 
traumatic exsanguination usually occurs rapidly, typically 
in the first 6–12 h [4–6]. Approximately 10 % of these 
injured patients are transfused with one or more units of 
blood, and up to 30 % require a massive transfusion (MT), 
defined as 10 or more units of blood, in the first 24 h after 
admission [7, 8]. However, there are few simple crite-
ria to predict the need for a massive transfusion (MT) in 
severe trauma patients. As previously reported, the assess-
ment blood consumption (ABC) [9] and trauma-associated 
severe hemorrhage (TASH) [10] scoring systems are use-
ful predictors of the need for MT. However, these scoring 
systems require the assessment of several factors, such as 
vital signs, focused assessment with sonography for trauma 
(FAST), pelvic fracture and/or femur fracture, making them 
slightly complicated. Therefore, we need to find some use-
ful biomarkers for TM, which are easy to use in the emer-
gency department.
Routine laboratory-based coagulation tests, such as pro-
thrombin time/international normalized ratio (PT/INR), 
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Background Assessment blood consumption and trauma-
associated severe hemorrhage scores are useful for predict-
ing the need for massive transfusion (MT) in severe trauma 
patients. However, fibrinogen (Fbg) and base excess (BE) 
levels might also be useful indicators for the need for MT. 
We evaluated the accuracy of prediction for MT of the 
scoring system vs. Fbg and BE.
Methods The subjects of this retrospective single center 
observational study were patients with injury severity 
score ≥16 trauma, divided into a non-MT group and an 
MT group. We compared variables, including the scoring 
system (comprising vital signs and focused assessment 
with sonography for trauma; FAST) and Fbg between the 
groups. We then performed a multiple logistic regression 
modeling and a receiver operating characteristic analysis to 
clarify which value was the most useful predictive indicator 
for MT.
Results There were 114 patients in the non-MT group 
and 39 in the MT group. The level of Fbg and BE were 
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activated partial thromboplastin time (APTT) and fibrino-
gen (Fbg), platelet count, and hemoglobin (Hb) concentra-
tion are used to assess the patient’s coagulation status [11]. 
Schreiber et al. [12] reported that, in military casualties, 
coagulopathy was identified as a factor contributing to the 
need for MT. However, when severe bleeding occurs dur-
ing surgery, coagulation factors do not decrease in a pre-
dictable manner. Conversely, it was recently reported that 
the Fbg level decreased earlier than other blood coagulation 
factors [13–15]. Stinger et al. [16] reported that the Fbg-
to-Packed red blood cells (PRBCs) ratio (F/R) was inde-
pendently associated with mortality [odds ratio (OR) 0.37, 
95 % confidence interval (CI) 0.171–0.812, p = 0.013], and 
that the incidence of death from hemorrhage was signifi-
cantly higher in the low-F/R ratio group than in the high-
F/R ratio group, with mortality rates of 85 % (23/27) vs. 
44 % (21/48), respectively, p < 0.001). They suggested that 
Fbg might play an important role in mortality and predict 
the need for MT. On the other hand, Kudo et al. reported 
that the Fresh frozen plasma (FFP)-to-PRBCs ratio dur-
ing the first 6 h of admission might not affect mortality or 
morbidity [17]. Thus, there is not yet a unified view about 
whether Fbg administration affects the morbidity and mor-
tality of severe trauma patients. Moreover, to our knowl-
edge, there has been no investigation to define the optimal 
plasma Fbg level that would indicate if MT is required.
Based on the finding that base excess (BE) was a use-
ful predictor of the need for volume replacement in trauma 
patients [18], this is now widely used in the evaluation of 
patients who have suffered severe trauma. We conducted 
the present study to evaluate the usefulness of other predic-
tors of MT in comparison with previous scoring systems, 
such as the ABC and TASH scores, in patients with blunt 
trauma.
Methods
This single center, retrospective study was conducted 
at Fukuoka University Hospital between June 2009 and 
December 2011. The study protocol was approved by the 
institutional review board of Fukuoka University Hospital 
according to the Declaration of Helsinki. Informed con-
sent was waived in view of the retrospective and anony-
mous nature of the study. We enrolled blunt trauma patients 
with an injury severity score (ISS) ≥16 who were admit-
ted to the hospital. MT was defined as the transfusion of 
10 units or more of PRBCs in the first 24 h after admis-
sion. In Japan, one unit of PRBC represents a volume of 
about 120 mL. Patients who were expected to require more 
than 10 units of PRBC within 24 h, but did not survive for 
24 h due to uncontrolled bleeding, were enrolled in the MT 
group to reduce survivor bias. The reason we enrolled these 
three patients in the MT group was based on the criteria of 
previous studies [19, 20] for the grouping of patients.
After allocating patients to an MT group or a non-MT 
group, we compared the two groups for age, sex, type of 
trauma (penetrating or blunt), ISS, Glasgow coma scale 
(GCS), systolic blood pressure (SBP) (mmHg), heart rate 
(HR) (/min), respiratory rate (RR) (/min), unstable pel-
vic fracture (UPF), femur fracture open/dislocated (FF 
O/D), FAST positive rate, hemoglobin (Hb) (g/dL), BE 
(mmol/L), ABC [9] and the TASH [10] scores, and Fbg 
level (mg/dL), INR, APTT (s), blood transfusion, opera-
tive management rate, and interventional radiology (IVR) 
at the time of admission. We also compared the 24 h and 
28-day mortality rates between the groups and evaluated 
the usefulness of predictors for MT using logistic regres-
sion analysis.
Blood samples
Blood samples were collected at the time of arrival at the 
ER and before the administration of fluids. Whole blood 
was collected with sodium citrate as an anticoagulant, in a 
conventional blood collection tube (NIPRO, Osaka, Japan). 
Several hemostatic markers, including the Fbg level, were 
measured within an hour after collection.
Statistical analysis
Continuous variables are presented as the median and 
interquartile range (IQR). We used the Chi-square test 
(or Fisher’s exact test, whichever was appropriate) or the 
Wilcoxon test to compare the two groups. To identify the 
risk factors for MT, we performed univariate and multiple 
logistic regression modeling. A receiver operating char-
acteristic (ROC) analysis was done to establish the most 
useful MT predictor. The Youden index was used to iden-
tify the cutoff values for levels of Fbg, BE, ABC score and 
TASH score, which may have MT significance. All analy-
ses were calculated by the JMP® version 10 (SAS institute, 
Tokyo, Japan). p values less than 0.05 were considered 
significant.
Results
We enrolled 153 patients who had suffered severe blunt 
trauma within the given investigation period. There were 
114 patients in the non-MT group and 39 patients in the 
MT group. Table 1 summarizes their demographic and 
clinical characteristics. Three patients who we included in 
the MT group were transfused with less than 10 units of 
PRBCs but died of uncontrolled massive bleeding within 
24 h. The massive bleeding was from severe hemothorax in 
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one, intra-abdominal hemorrhage secondary to liver injury 
in another one, and an unstable pelvic fracture in the other.
The RR, HR, ISS, FAST positive rate, UPF rate, ABC 
score, TASH score, INR, APTT, blood transfusion number 
(PRBCs, FFP, PC), pelvic external rotation rate, thoracotomy 
rate, laparotomy rate, IVR rate, 24 h mortality, and 28-day 
mortality were all significantly higher in the MT group. 
However, the ratio of male patients as well as SBP, Hb, BE, 
and Fbg levels were significantly lower in the MT group.
We evaluated the predictors of MT using a univariate 
logistic regression model, which revealed gender (male), 
HR (>120/min.), SBP (<90 mmHg), FAST positivity, UPF 
positivity, Hb, BE, and Fbg levels as useful predictors for 
MT (Table 2). We then performed multiple logistic regres-
sion modeling analysis. Explanatory values were selected 
by the significant predictors for MT in univariate analy-
sis, which included gender, HR (<120/min vs. 120/min), 
SBP (<90 mmHg vs. 90 mmHg), FAST (positivity vs. 
negativity), UPF (positivity vs. negativity), Hb (g/dL), BE 
(mmol/L), and Fbg (mg/dL). From this result, a low level of 
Fbg and BE were independent predictors of MT (p < 0.01, 
p < 0.05, respectively; Table 3).
Table 1  Demographics and 
clinical characteristics of blunt 
trauma patients who did not 
need massive blood transfusion 
vs. those who did
MT massive transfusion, IQR interquartile range, SBP systolic blood pressure, HR heart rate, ISS injury 
severity score, FAST focused assessment with sonography for trauma, Hb hemoglobin, BE base excess, 
ABC score assessment of blood consumption score, TASH score trauma-associated severe hemorrhage 
score, INR international normalized ratio, APTT activated partial thromboplastin time, Fbg fibrinogen, 
PRBCs packed red blood cells, FFP fresh-frozen plasma, PC platelet concentrates, IVR interventional radi-
ology
Variables Non-MT group (n = 114) MT group (n = 39) p value
Age, median (IQR) 58 (32 to 69) 57 (37 to 77) NS
Male (%) 72.8 48.7 <0.01
Glasgow coma scale, median (IQR) 14 (12 to 15) 13 (7 to 14) <0.05
SBP (mmHg), median (IQR) 130 (108 to 151) 109 (84 to 146) <0.01
RR/min, median (IQR) 20 (18 to 24) 24 (17 to 28) <0.05
HR/min, median (IQR) 84 (68 to 95) 103 (85 to 122) <0.0001
ISS, median (IQR) 22 (17 to 25) 27 (22 to 34) <0.01
FAST positive (%) 12.3 33.3 <0.01
Hb (mg/dL), median (IQR) 13.4 (11.6 to 15) 11.3 (9.2 to 12.9) <0.0001
BE (mmol/L), median (IQR) 0.1 (−1.7 to 1.0) −3.8 (−9.3 to −1.7) <0.0001
Unstable pelvic fracture (%) 5.3 25.6 <0.001
Femur fracture open/dislocated (%) 4.4 12.8 NS
Penetrating (%) 1.8 2.6 NS
Antiplatelet argent (%) 7 0 NS
Anticoagulant argent (%) 3.5 2.6 NS
Liver disease (%) 0.9 0 NS
ABC score, median (IQR) 0 (0 to 0) 1 (0 to 2) <0.0001
TASH score, median (IQR) 3 (1 to 4) 8 (5 to 13) <0.0001
INR, median (IQR) 1.07 (1 to 1.17) 1.2 (1.05 to 1.43) <0.001
APTT (s), median (IQR) 25.9 (23.9 to 28.7) 28.3 (25.8 to 37) <0.01
Fbg (mg/dL), median (IQR) 241 (191 to 311) 167 (96 to 205) <0.0001
PRBCs within 24 h U, median (IQR) 0 (0 to 3) 12 (10 to 20) <0.0001
FFP within 24 h U, median (IQR) 0 (0 to 0) 10 (5 to 15) <0.0001
PC within 24 h U, median (IQR) 0 (0 to 0) 10 (0 to 10) <0.0001
Pelvic external rotation (%) 4.4 15.4 <0.05
Thoracotomy (%) 0.9 12.8 <0.01
Laparotomy (%) 2.6 7.7 NS
Craniotomy (%) 21.1 23.1 NS
IVR (%) 2.6 20.5 <0.001
24-h mortality (%) 5.3 38.5 <0.0001
28-day mortality (%) 6.1 46.2 <0.0001
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Finally, we performed the receiver operating characteris-
tics (ROC) analysis, and calculated the area under the curve 
(AUC) to clarify which factor is the most useful predictor 
for MT. The highest AUC was achieved for BE (0.845) fol-
lowed by the TASH score (0.833), Fbg (0.765), and then 
the ABC score (0.716). The optimal cutoff values for BE 
and Fbg were −1.4 mmol/L and 211 mg/dL, respectively. 
According to the AUC value, TASH and BE were sig-
nificantly higher than the ABC score (p < 0.01, p < 0.01, 
respectively; Table 4), but not the Fbg level.
Discussion
Our study demonstrated that low levels of Fbg and BE were 
independent predictors of the need for MT in patients who 
have suffered severe blunt trauma. Both Fbg and BE levels 
are easy to measure and are already recognized as global 
markers. Consequently, there are already a few models 
being used to predict the need for MT, including the ABC 
score [9] and the TASH score [10]. However, these scor-
ing systems include several variables, such as age, sex, vital 
signs, FAST, UPF, Hb, and BE, and require considerable 
time and effort to calculate the score. Hence, a simpler and 
faster indicator for MT in patients with active bleeding is 
needed.
This study showed that not only the BE level but also 
the Fbg level are independent predictive factors for MT. 
Recently, Yumoto et al. [20] reported that the BE level 
was a useful predictor of MT, while Soderlund et al. [21] 
found that mortality after blunt thoracic injury was closely 
associated with the BE level on admission. Some investi-
gators also proposed that measures of hypoperfusion, such 
as lactate or BE levels, should be incorporated into the MT 
scoring systems [10, 22]. In fact, several studies about MT 
scoring systems have concluded that BE levels or serum 
Table 2  Univariate logistic 
regression model for the 
predictors of massive 
transfusion
MT massive transfusion, OR odds ratio, CI confidence interval, Hb hemoglobin, Fbg fibrinogen, BE base 
excess
Variables of ABC and TASH scores p value OR 95 % CI
Sex (male vs. female) <0.01 0.355 0.166–0.751
Mechanism (penetrating vs. blunt) NS 1.474 0.067–15.799
Heart rate (≥120/min vs. <120/min) <0.001 6.005 12.170–17.692
Systolic blood pressure (<90 vs. ≥90 mmHg) <0.001 0.193 0.072–0.501
Focused assessment with sonography for trauma (positive vs. negative) <0.01 3.571 1.490–8.589
Unstable pelvic fracture (positive vs. negative) <0.001 6.207 2.129–19.606
Femur fracture open/dislocated (positive vs. negative) NS 3.206 0.846–12.173
Hb (mg/dL) <0.0001 0.716 0.605–0.834
BE (mmol/L) <0.0001 0.767 0.681–0.847
Fbg (mg/dL) <0.0001 0.987 0.981–0.992
Table 3  Multiple logistic regression model for the predictors of mas-
sive transfusion
Other variables entered in the model were: sex, systolic blood pres-
sure (SBP) <90 vs. ≥90 mmHg, focused assessment with sonography 
for trauma (FAST) positive vs. negative, heart rate (HR) <120/min 
vs. ≥120/min, base excess (BE) (mmol/L), unstable pelvic fracture 
(UPF) positive vs. negative, hemoglobin (Hb) (mg/dL)
MT massive transfusion, OR odds ratio, CI confidence interval, BE 
base excess, Fbg fibrinogen
Variables p value OR 95 % CI
BE (mmol/L) <0.05 0.855 0.745–0.971
Fbg (mg/dL) <0.01 0.992 0.986–0.998
Table 4  Results of receiver operating characteristics analysis for massive transfusion
ROC receiver operating characteristics, MT massive transfusion, AUC area under the curve, CI confidence interval, ABC assessment blood con-
sumption, TASH trauma-associated severe hemorrhage, Fbg fibrinogen, BE base excess
* p < 0.01 vs. ABC score
Variables AUC 95 % CI Optimal  
cutoff value
Sensitivity Specificity Positive predict  
value
Negative predict 
value
ABC score 0.724 0.628–0.803 1 64 78 25 89
TASH score 0.833* 0.744–0.895 5 77 77 30 88
Fbg (mg/dL) 0.765 0.683–0.898 211 78 65 34 81
BE (mmol/L) 0.845* 0.683–0.848 −1.4 80 67 31 76
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lactate concentrations should be adopted as a component of 
the prediction of MT [10, 20, 22]. These reports strongly 
supported our results.
On the other hand, Fbg plays an essential role in the 
hemostatic coagulation systems linked to activated plate-
lets and the formation of a fibrin network [23]. Addition-
ally, a decrease in Fbg was more rapid than that in any 
other coagulation factor when plasma-poor blood trans-
fusion or extracellular fluids were infused in patients 
with major blood loss [24]. When the Fbg level falls to 
40 % of the normal level, a bleeding tendency ensues. 
On the other hand, a bleeding tendency does not develop 
when other coagulation factors (prothrombin, factor V, 
factor VII) fall to about 20 % of normal [24]. Inaba et al. 
[25] reported that the Fbg level increase correlates with 
improved survival rates for patients who required MT. 
Furthermore, they concluded that an Fbg level <100 mg/
dL was a strong independent risk factor for death. It is 
well known that maintaining a high Fbg level improves 
the survival rate, but our study also suggests that the Fbg 
level is one of the most important predictors of the need 
for MT, in comparison with other coagulation factors, in 
trauma patients.
Our study demonstrated that the optimal cutoff value for 
the Fbg level on admission was 211 mg/dL (normal range 
200–400 mg/dL with up to a 10-fold increase during tis-
sue damage, infection, and cytokine-induced inflamma-
tory responses [26], and with less than 100 mg/dL of Fbg 
predictive of microvascular bleeding [24]). Fenger-Eriksen 
et al. [26] reported that patients with serious bleeding, in 
whom a fibrinogen concentrate had been administered to 
treat hypofibrinogenaemia (defined by a laboratory thresh-
old value below 200 mg/dL) had significantly less blood 
loss and transfusion requirements (RBC, FFP and plate-
lets). This threshold is similar to that according to our 
results, which revealed that the level of Fbg for MT was 
less than 211 mg/dL in blunt trauma patients at the time of 
admission.
We included in our MT group, three patients who died 
of uncontrolled massive bleeding within 24 h. The Fbg lev-
els were already extremely low in all three on arrival (89, 
50, 163 mg/dL, respectively). This also suggested that a 
low Fbg level on admission might predict the clinical out-
come of trauma patients.
In Japan, a portable Fbg analyzer CG02N (A&T Cor-
poration, Kanagawa, Japan) has recently become available 
for clinical use. With this device, the Fbg level in a blood 
sample is available in about 1 min. We consider this mobile 
Fbg analyzer as a point of care testing in the emergency 
room and the bedside in the intensive care unit (ICU). We 
will attempt to validate the results of this study in relation 
to the usefulness of the Fbg level as predictor for MT by 
using CG02N in the near future.
This study has some limitations. First, it was retrospec-
tive and the sample size was small. Second, we did not con-
sider the presence of severe head injury, although Lee et al. 
[27] reported recently that traumatic brain injury was not 
independently associated with more profound coagulopa-
thy. Third, we could not examine the potential influence 
of the patient’s transport time and the fluids administered 
prior to admission to our center. Fourth, in this study we 
examined Fbg levels on admission only.
Conclusions
This study demonstrated that Fbg and BE levels as a sin-
gle factor could predict the need for MT. We recommend 
that Fbg and BE levels be measured on admission and as 
point of care testing, especially in patients who have suf-
fered blunt trauma.
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